Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 23, 2023, titled “Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005% 0.064%”…….
| Subscribe To Our Free Newsletter |
